KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Other Operating Expenses (2017 - 2025)

Guardant Health's Other Operating Expenses history spans 9 years, with the latest figure at $242.9 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 33.19% year-over-year to $242.9 million; the TTM value through Dec 2025 reached $843.7 million, up 28.86%, while the annual FY2025 figure was $843.7 million, 28.86% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $242.9 million at Guardant Health, up from $221.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $242.9 million in Q4 2025 and bottomed at $63.1 million in Q1 2021.
  • The 5-year median for Other Operating Expenses is $128.9 million (2022), against an average of $143.8 million.
  • The largest annual shift saw Other Operating Expenses surged 75.11% in 2021 before it dropped 18.97% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at $93.0 million in 2021, then skyrocketed by 38.19% to $128.5 million in 2022, then surged by 75.07% to $225.0 million in 2023, then dropped by 18.97% to $182.4 million in 2024, then surged by 33.19% to $242.9 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Other Operating Expenses are $242.9 million (Q4 2025), $221.0 million (Q3 2025), and $200.8 million (Q2 2025).